Back

Xeris Biopharma Holdings Quote, Financials, Valuation and Earnings

Buy

XERS
Xeris Biopharma Holdings

Last Price:

2.03

Seasonality Move:

-12.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Xeris Biopharma Holdings Price Quote

$2.03

+0.05 (+2.53%)

(Updated: May 16, 2024 at 6:55 PM ET)

Xeris Biopharma Holdings Key Stats

Buy

Xeris Biopharma Holdings (XERS) is a Buy

Day range:

$1.91 - $2.05

52-week range:

$1.46 - $3.26

Dividend yield:

P/E ratio:

0.00

P/S ratio:

1.48

P/B ratio:

Volume:

1.8M

Avg. volume:

1.4M

1-year change:

-30.28%

Market cap:

$260.9M

Revenue:

$163.9M

EPS:

$-0.44

How Much Does Xeris Biopharma Holdings Make?

How Much Are Xeris Biopharma Holdings's Sales Annually?
XERS Revenues are $163.9M
How Much Profit Does Xeris Biopharma Holdings's Make A Year?
XERS net income is -$62.3M

Is Xeris Biopharma Holdings Growing As A Company?

What Is Xeris Biopharma Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34%
What Is Xeris Biopharma Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Xeris Biopharma Holdings Stock Price Performance

Did Xeris Biopharma Holdings Stock Go Up Last Month?
Xeris Biopharma Holdings share price went up by 7.03% last month
Did XERS's Share Price Rise Over The Last Year?
XERS share price fell by -30.28% over the past 1 year

What Is Xeris Biopharma Holdings 52-Week High & Low?

What Is Xeris Biopharma Holdings’s 52-Week High Share Price?
Xeris Biopharma Holdings has traded as high as $3.26 over the past 52 weeks
What Is Xeris Biopharma Holdings’s 52-Week Low Share Price?
Xeris Biopharma Holdings has traded as low as $1.46 over the past 52 weeks

Xeris Biopharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xeris Biopharma Holdings?

How Much Debt Does Xeris Biopharma Holdings Have?
Total long term debt quarterly is $190.9M
How Much Cash Does Xeris Biopharma Holdings Have?
Cash and short term investments quarterly total is $72.5M
What Is Xeris Biopharma Holdings’s Book Value Per Share?
Book value per share is -0.05

Is Xeris Biopharma Holdings Cash Flow Positive?

What Is XERS Cash Flow From Operations?
Cash flow from operations (TTM) is -$47M
What Is Xeris Biopharma Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.6M
What Is Xeris Biopharma Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6M

Xeris Biopharma Holdings Return On Invested Capital

Is Management Doing A Good Job?
XERS return on invested capital is -30.22%
What Is Xeris Biopharma Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -18.92%
What Is XERS Return On Equity?
ROE is a measure of profitability and is -362.12%

Xeris Biopharma Holdings Earnings Date & Stock Price

What Is Xeris Biopharma Holdings's Stock Price Today?
A single share of XERS can be purchased today for 1.98
What Is Xeris Biopharma Holdings’s Stock Symbol?
Xeris Biopharma Holdings trades on the nasdaq under the ticker symbol: XERS
When Is Xeris Biopharma Holdings’s Next Earnings Date?
The next quarterly earnings date for Xeris Biopharma Holdings is scheduled on August 8, 2024
When Is XERS's next ex-dividend date?
Xeris Biopharma Holdings's next ex-dividend date is May 17, 2024
How To Buy Xeris Biopharma Holdings Stock?
You can buy Xeris Biopharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Xeris Biopharma Holdings Competitors

Who Are Xeris Biopharma Holdings's Competitors?
Below is a list of companies who compete with Xeris Biopharma Holdings or are related in some way:
- Adial Pharmaceuticals Inc (ADIL)
- Kodiak Sciences Inc (KOD)
- Phathom Pharmaceuticals Inc (PHAT)
- Regeneron Pharmaceuticals Inc (REGN)
- Vanda Pharmaceuticals Inc (VNDA)

Xeris Biopharma Holdings Dividend Yield